| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 793.75B | 768.13B | 721.09B | 720.58B | 713.77B |
| Gross Profit | 227.62B | 222.87B | 209.59B | 210.88B | 209.68B |
| EBITDA | 37.51B | 33.51B | 25.44B | 28.13B | 31.73B |
| Net Income | 15.45B | 14.12B | 9.02B | 11.39B | 13.11B |
Balance Sheet | |||||
| Total Assets | 433.55B | 434.83B | 431.69B | 369.37B | 377.97B |
| Cash, Cash Equivalents and Short-Term Investments | 8.96B | 8.83B | 12.01B | 13.23B | 29.89B |
| Total Debt | 70.32B | 81.77B | 91.21B | 46.02B | 55.56B |
| Total Liabilities | 198.59B | 211.89B | 216.78B | 167.71B | 178.48B |
| Stockholders Equity | 234.43B | 222.52B | 214.61B | 201.66B | 199.48B |
Cash Flow | |||||
| Free Cash Flow | 20.37B | 21.38B | -46.47B | 6.72B | 3.13B |
| Operating Cash Flow | 30.83B | 30.71B | 19.96B | 12.14B | 10.58B |
| Investing Cash Flow | -15.10B | -15.43B | -68.72B | -8.34B | -10.52B |
| Financing Cash Flow | -15.61B | -18.46B | 47.53B | -20.45B | -13.24B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥33.26B | 10.78 | ― | 3.77% | 17.14% | 8.81% | |
75 Outperform | ¥439.94B | 8.07 | ― | 1.35% | 15.16% | 20.54% | |
67 Neutral | ¥301.67B | 18.33 | ― | 2.72% | 2.94% | 63.59% | |
66 Neutral | ¥296.57B | 11.66 | 11.17% | 2.61% | 5.12% | 12.69% | |
63 Neutral | ¥244.36B | 14.76 | ― | 2.23% | 3.33% | 9.04% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
57 Neutral | ¥501.71B | 23.87 | 4.18% | 2.57% | 3.85% | -43.62% |